| Literature DB >> 28325479 |
Adam P Chambers1, Joyce E Sorrell2, April Haller2, Karen Roelofs3, Chelsea R Hutch3, Ki-Suk Kim3, Ruth Gutierrez-Aguilar4, Bailing Li2, Daniel J Drucker5, David A D'Alessio6, Randy J Seeley3, Darleen A Sandoval7.
Abstract
Glucagon-like peptide 1 (GLP-1) is necessary for normal gluco-regulation, and it has been widely presumed that this function reflects the actions of GLP-1 released from enteroendocrine L cells. To test the relative importance of intestinal versus pancreatic sources of GLP-1 for physiological regulation of glucose, we administered a GLP-1R antagonist, exendin-[9-39] (Ex9), to mice with tissue-specific reactivation of the preproglucagon gene (Gcg). Ex9 impaired glucose tolerance in wild-type mice but had no impact on Gcg-null or GLP-1R KO mice, suggesting that Ex9 is a true and specific GLP-1R antagonist. Unexpectedly, Ex-9 had no effect on blood glucose in mice with restoration of intestinal Gcg. In contrast, pancreatic reactivation of Gcg fully restored the effect of Ex9 to impair both oral and i.p. glucose tolerance. These findings suggest an alternative model whereby islet GLP-1 also plays an important role in regulating glucose homeostasis.Entities:
Keywords: GLP-1; glucose homeostasis; incretin
Mesh:
Substances:
Year: 2017 PMID: 28325479 PMCID: PMC5385998 DOI: 10.1016/j.cmet.2017.02.008
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287